Under pathological circumstances, it has been shown that PACAP decreases inflammatory reactions both in the small and in the large intestine, while lack of PACAP is associated with increased inflammatory reactions and colon cancer development (4–6). Here, ADCYAP1 is linked to malignant colon neoplasm.